Back to School: How biopharma can reboot drug development. Access exclusive analysis here
ONXX gained $8.68 (18%) to $58.03 on Wednesday after the company reported late Tuesday that it swung to a
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury